Health
New COVID-19 Vaccine Candidate Provides Effective Option for Low- to Mid-Income Countries – The Ritz Herald
A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation…
A multidisciplinary team of researchers is the first to show combining yeast-expression technology and a novel adjuvant formulation to produce a COVID-19 vaccine candidate is effective against SARS-COV-2 and promises to be easy to produce at large scale…
Continue Reading
-
Noosa News17 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business17 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News17 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business21 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?